Biotechnology Small-Cap Firm Century Therapeutics’ Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing – Century Therapeutics (NASDAQ:IPSC) Read more
Stockmarkets AstraZeneca to buy Amolyt Pharma for $1.05 billion to boost rare diseases portfolio Reuters via biedexmarkets.com Read more
Biotechnology Nanotechnology’s Promising Role In Fighting Infectious Diseases: Protecting Surfaces With FendX’s Nanotechnology – AstraZeneca (NASDAQ:AZN), FendX Technologies (OTC:FDXTF) Read more
Biotechnology Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD 2024 International Conference – Athira Pharma (NASDAQ:ATHA) Read more
Stockmarkets Coeptis expands license for CAR technology to autoimmune diseases By biedexmarkets.com Read more
Biotechnology Coya Therapeutics Secures Key Financing In Its Fight Against Myriad Diseases – Coya Therapeutics (NASDAQ:COYA) Read more
Opinion Maria Cho, A Diversity Leader And CEO Of A Company Vying For Global Food Security And Treatments Against Diseases Of The Future Read more